DFW Capital Partners leads equity investment in Sebela Pharmaceuticals

DFW Capital Partners announced today that on August 26, 2013 it completed an equity investment in the parent entity of Sebela International, Ltd and Sebela Pharmaceuticals, Inc. (“Sebela”), a newly-formed specialty pharmaceutical acquisition and licensing platform.  Joining DFW in the equity investment was Sebela’s executive management team, members of which had previously led a former… Read more »

DFW Capital Partners closes significant equity investment in Vidara Therapeutics

DFW Capital Partners announced today that on June 19, 2012, it completed an equity investment in Vidara Therapeutics (“Vidara”), a newly-formed specialty pharmaceutical acquisition and licensing platform.  Joining DFW in the equity investment was Vidara’s executive management team, members of which had previously led a former DFW portfolio company, Alaven Pharmaceutical, through significant growth and… Read more »

DFW Capital Partners sells Northeast Dental Management

DFW Capital Partners announced today the sale of Northeast Dental Management (“NEDM”). NEDM is a leading dental practice management company serving the New Jersey, New York, Pennsylvania and Virginia markets. Terms of the transaction were not disclosed. Based in Paramus, New Jersey, NEDM offers a full suite of management services to dental practices located in… Read more »

DFW Invests in Meta Pharmaceutical Services

DFW Capital Partners announced today that it has closed the recapitalization of Meta Pharmaceutical Services, a leading outsourced service provider to the pharmaceutical industry. DFW invested preferred equity, and raised senior and subordinated debt financing, to facilitate a liquidity event for Meta’s founders, while leaving the core operating team with a significant remaining equity stake.… Read more »

Alaven Pharmaceutical Acquires DrNatura Line of Consumer Health Remedies

December 15, 2008, Teaneck, NJ. DFW Capital Partners announced today that its portfolio company, Alaven Pharmaceutical, has acquired the assets of DrNatura, a leading web-based direct-to-consumer marketer of colon and digestive health products. As part of the transaction, Alaven created a separate subsidiary, Alaven Consumer Health, to house DrNatura and Alaven’s other OTC Alaven products.… Read more »

DFW Capital Partners successfully exits its investment in ConsoliDent

DFW Capital Partners announced today that it has completed the sale of its portfolio company, ConsoliDent to Great Expressions Dental, a portfolio company of Audax Group. DFW realized a 2.2x aggregate ROI on its investment in ConsoliDent. DFW originally invested in ConsoliDent, a leading regional dental practice management company, in 1998, as the company established… Read more »

Garden State Dental Management closes the acquisition of Family Dental

Garden State Dental Management closes the acquisition of Family Dental Garden State Dental Management (“GSDM”) announced today that it has closed the acquisition of Family Dental in New York. The add-on acquisition was funded in part by funds from DFW Capital Partners III L.P. The transaction adds five new offices to the GSDM platform nearly… Read more »